Patterson Companies

Patterson Cos., Inc. provides products, technologies, services, and business solutions to the dental and animal health markets. It operates through the following segments: Dental, Animal Health, and Corporate. The Dental segment provides consumable dental products, equipment and software, turnkey digital solutions, and value-added services to dentists, dental laboratories, institutions, and other healthcare professionals. The Animal Health segment distributes animal health products, services, and technologies to both the production-animal and companion-pet markets. The Corporate segment consists of general and administrative expenses, including home office support costs in areas such as information technology, finance, legal, human resources, and facilities. The company was founded by John Patterson and Myron Fayette Patterson in 1877 and is headquartered in St. Paul, MN.

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Patterson Companies Inc. reports strong Q4 performance and outlines growth strategies for fiscal 2024

Patterson Companies Inc. delivered strong financial results for Q4 2023, with a focus on sustained margin improvement and strategic growth opportunities. Despite challenges in free cash flow and market moderation, the company is well-positioned to leverage its strengths and capitalize on opportunities in the dental and animal health segments.

Patterson Companies Inc. reports strong Q2 earnings and focuses on private label growth

Patterson Companies Inc. delivered strong financial performance in Q2 2023, driven by growth in both the Dental and Animal Health segments. The company reaffirmed fiscal '24 earnings guidance and highlighted the potential of private label products. Despite tax and interest rate challenges, the company remains optimistic and focused on strategic initiatives to drive future growth.

Patterson Companies excels in Q3, eyes international growth opportunities

Patterson Companies reported a strong Q3 performance with internal sales growth and margin improvements. Challenges in the Dental segment were offset by growth in the Animal Health segment. The company highlighted strategic acquisitions, leadership appointments, and operational enhancements as key drivers of success. Opportunities lie in stable patient traffic, international investments, and exploring M&A in dental specialties for future growth.

Patterson Companies reports strong Q4 performance and strategic growth focus

Patterson Companies had a robust Q4 performance, showcasing growth in sales and margins. Despite challenges in the companion animal market, the company is strategically positioned for growth through software investments and service enhancements. Opportunities lie in sustained sales growth, margin expansion, and strategic market positioning.

Patterson Companies reports strong Q1 results amidst strategic focus

Patterson Companies delivered strong Q1 '24 results with growth in sales and adjusted EPS. The company is strategically focusing on private label products and efficiency improvements. While facing challenges like deflationary impacts and inflationary pressures, Patterson sees opportunities in Dental equipment growth and continued investments for long-term profitability.

Patterson Companies reports strong Q2 performance amidst market challenges

Patterson Companies delivered a solid performance in Q2 2024, driven by growth in Dental and Animal Health segments.
Despite challenges like macroeconomic headwinds and pricing pressures, the company remains focused on efficiency and driving demand.
Opportunities exist for Patterson to capitalize on market trends, optimize operations, and explore new growth avenues.
Investors should monitor how Patterson navigates challenges and leverages strengths to achieve its revised fiscal guidance.

Patterson Companies reports solid Q3 performance amidst market challenges

Patterson Companies delivered a solid performance in Q3 2024, with a focus on revenue growth, margin expansion, and strategic investments in distribution and software offerings.
While facing challenges in certain segments, the company remains committed to operational efficiency, margin integrity, and long-term growth initiatives.
Opportunities lie in sustaining sales growth, expanding market presence, and capitalizing on improvements in equipment demand and margin enhancement.
Overall, Patterson's strategic focus on growth, efficiency, and innovation positions the company for long-term success in the market.

Patterson Companies Reports Stable Q4, Eyes Strategic Growth

Patterson Companies concluded fiscal 2024 with stable financial performance, facing some headwinds in the Dental segment but offset by gains in Animal Health and strategic tech investments. The company is poised for modest growth in 2025, backed by ongoing investments in high-margin areas and a strong focus on innovation and market expansion.

Patterson Companies addresses challenges in Q1 2025 earnings call

Patterson Companies faced challenges in Q1 2025, with declines in both the Dental and Animal Health segments.
Despite these challenges, management is taking actions to improve performance and profitability for the rest of fiscal 2025.
The company's focus on cost management and operational efficiency is a strength in navigating the current environment.
Opportunities exist in strengthening the companion animal business, improving internal sales, and enhancing cybersecurity measures.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Patterson Cos., Inc. engages in the provision of products, technologies, services, and business solutions to the dental and animal health markets. It operates through the following segments: Dental, Animal Health, and Corporate. The Dental segment provides consumable dental products, equipment and software, turnkey digital solutions, and value-added services to dentists, dental laboratories, institutions, and other healthcare professionals. The Animal Health segment distributes animal health products, services, and technologies to both the production-animal and companion-pet markets. The Corporate segment consists of general and administrative expenses, including home office support costs in areas such as information technology, finance, legal, human resources, and facilities. The company was founded by John Patterson and Myron Fayette Patterson in 1877 and is headquartered in St. Paul, MN.

The company saw revenue and earnings per share rise over 2021 and over the fourth quarter of 2022. Its dental segment had the biggest sales increase in the quarter, up 8%, year over year.

Why Shares of Patterson Companies Shot Up Wednesday

Patterson Companies' (PDCO) fiscal fourth-quarter 2023 results reflect robust improvement in Dental Equipment sales, Value-added services and Animal Health segment.

Patterson Companies (PDCO) Q4 Earnings Beat, Sales Hurt by FX

Patterson Companies, Inc. (NASDAQ:PDCO ) Q4 2023 Earnings Call Transcript June 21, 2023 8:30 AM ET Company Participants John Wright - Vice President, Investor Relations Don Zurbay - President and Chief Executive Officer Kevin Barry - Chief Financial Officer Conference Call Participants Jason Bednar - Piper Sandler Michael Cherny - Bank of America Nathan Rich - Goldman Sachs Jonathan Block - Stifel Nicolaus Jeff Johnson - Robert W. Baird Elizabeth Anderson - Evercore ISI Kevin Caliendo - UBS Brandon Vazquez - William Blair A.J.

Patterson Companies, Inc. (PDCO) Q4 2023 Earnings Call Transcript

PDCO stock rocketed nearly 15% Wednesday after pet, dental supplies maker Patterson topped Q4 views, provided a solid earnings outlook.

PDCO Stock Spikes After Pet, Dental Supplies Maker Beats Earnings

Patterson Companies, Inc shares jumped 15% to $32.40 in early Wednesday trading after the dental and animal health company reported fourth quarter 2023 revenue that rose 5% year over year to $1.72 billion, surpassing the FactSet consensus estimate of $1.66 billion. Patterson also generated $0.84 in adjusted earnings per share (EPS) during the quarter, topping the consensus analyst forecast of $0.70, as margins expanded and sales in its two primary segments, Dental and Animal Health, accelerated.

Patterson Companies stock climbs as 4Q financial results beat estimates

Patterson Cos. (PDCO) came out with quarterly earnings of $0.84 per share, beating the Zacks Consensus Estimate of $0.70 per share.

Patterson Cos. (PDCO) Q4 Earnings and Revenues Top Estimates

Patterson Cos. Inc.'s stock PDCO, -0.84% soared 10% premarket Wednesday, after the maker of dental and animal care products blew past estimates for its fiscal fourth quarter and offered upbeat guidance.

Patterson Cos.' stock soars 10% premarket after earnings blow past estimates

ST. PAUL, Minn.--(BUSINESS WIRE)--Patterson Companies, Inc. (Nasdaq: PDCO) today reported consolidated net sales of $1.72 billion (see attached Sales Summary for further details) in its fiscal fourth quarter ended April 29, 2023, an increase of 5.0 percent compared to the same period last year. Internal sales, which are adjusted for the effects of currency translation and contributions from recent acquisitions, increased 5.7 percent over the prior year period. Reported net income attributable t.

Patterson Companies Reports Fiscal 2023 Fourth Quarter and Year End Operating Results

ST. PAUL, Minn.--(BUSINESS WIRE)--Patterson Companies (Nasdaq: PDCO) today announced that Meenu Agarwal has been elected to the Patterson Companies Board of Directors, effective June 13, 2023. Ms. Agarwal currently serves as Group Senior Vice President, Customer Experience and Success of Workday, Inc., a leading provider of enterprise cloud applications for finance and human resources. Ms. Agarwal will serve on the Board's Audit and Finance Committee. “As we continue to enhance our software-as-.

Patterson Companies Elects Meenu Agarwal to Board of Directors

Investors remain optimistic about Patterson Companies (PDCO) on the back of its broad product line.

3 Reasons to Hold Patterson Companies (PDCO) Stock for Now

ST. PAUL, Minn.--(BUSINESS WIRE)--Patterson Companies (Nasdaq: PDCO) today announced that it will hold its fiscal 2023 fourth-quarter and year end conference call on Wednesday, June 21, 2023 at 7:30 a.m. CT (8:30 a.m. ET). The company's earnings release will be issued that morning before the market opens. To access the live webcast, go to the investor relations section of the company's website, www.PattersonCompanies.com. The fiscal 2023 fourth-quarter earnings conference call replay will be av.

Patterson Companies Fiscal 2023 Fourth Quarter and Year End Conference Call Scheduled for Wednesday, June 21, 2023

Patterson Companies appears undervalued, trading at a 40% P/E discount to peers. PDCO's earnings power and asset profitability, along with a potential mispricing on fundamental and valuation fronts, suggest the stock could be undervalued by 15-20%. The author reiterates PDCO as a buy, looking for a $3 billion market value or $31 per share, based on the company's growth initiatives and respectable dividend yield.

Patterson Companies: Earnings Power, Asset Factors Suggest Mispricing

CONMED

Investors interested in Medical - Dental Supplies stocks are likely familiar with Patterson Cos. (PDCO) and Conmed (CNMD).

PDCO or CNMD: Which Is the Better Value Stock Right Now?

Here's Why You Should Retain Patterson Companies (PDCO) Stock Now

Investors are optimistic about Patterson Companies' (PDCO) strong product line.

Here's Why You Should Retain Patterson Companies (PDCO) Stock

CompX International

Chevron

Epsilon Energy Ltd

Packaging Corp of America

Sociedad Quimica Y Minera De Chile

Taitron Components

Although any time is a good time to consider the best retirement stocks to buy, the present juncture sparks perhaps unprecedented urgency. With the implosion of SVB Financial Group, the ripple effect might not just center on one troubled enterprise.

The 7 Best Retirement Stocks for Anxious Investors

In the last earnings report, Patterson Companies, Inc. saw a small increase in sales but instead managed to increase the net margins and impress investors. The management has a focus on giving back to shareholders in the shape of dividends.

Patterson Companies, Inc. Has Proven Itself

Patterson Companies has had a rather mixed operating history in recent years, with sales climbing, but profits and cash flows posting volatile results. That trend has continued into the 2023 fiscal year, though cash flow data is looking up.

Patterson Companies: A Prospect To Brighten Your Smile

Patterson Companies' (PDCO) fiscal third-quarter 2023 results are negatively impacted by unfavorable currency movements.

Patterson Companies (PDCO) Q3 Earnings Beat, Sales Hurt by FX

Patterson Cos. (PDCO) delivered earnings and revenue surprises of 3.33% and 1.15%, respectively, for the quarter ended January 2023.

Patterson Cos. (PDCO) Surpasses Q3 Earnings Estimates

ST. PAUL, Minn.--(BUSINESS WIRE)--Patterson Companies, Inc. (Nasdaq: PDCO) today reported consolidated net sales of $1.60 billion (see attached Sales Summary for further details) in its fiscal third quarter ended January 28, 2023, an increase of 0.3 percent compared to the same period last year. Internal sales, which are adjusted for the effects of currency translation and contributions from recent acquisitions, increased 1.8 percent over the prior year period.

Patterson Companies Reports Fiscal 2023 Third Quarter Operating Results

ST. PAUL, Minn.--(BUSINESS WIRE)--Patterson Companies (Nasdaq: PDCO) today announced that it will hold its fiscal 2023 third-quarter earnings conference call on Thursday, March 2, 2023 at 7:30 a.m. CT (8:30 a.m. ET). The company's earnings release will be issued that morning before the market opens. To access the live webcast, go to the investor relations section of the company's website, www.PattersonCompanies.com.

Patterson Companies Fiscal 2023 Third Quarter Conference Call Scheduled for Thursday, March 2, 2023

Reasons to Retain Patterson Companies (PDCO) Stock Now

ST. PAUL, Minn.--( BUSINESS WIRE )--Patterson Companies, Inc. (Nasdaq: PDCO), announced that it has, through subsidiaries, successfully completed the previously announced acquisition of substantially all of the assets of Relief Services for Veterinary Practitioners and Animal Care Technologies (“RSVP” and “ACT,” respectively), Texas-based companies that provide innovative solutions to veterinary practices through data extraction and conversion, staffing and video-based training services.

Patterson Closes Acquisition of Relief Services for Veterinary Practitioners and Animal Care Technologies

ST. PAUL, Minn.--( BUSINESS WIRE )--Patterson Companies, Inc. (Nasdaq: PDCO) today announced enhancements to its executive leadership team to further support the execution of its strategy. Kevin Barry, most recently the Company's Interim Chief Financial Officer, has been named Chief Financial Officer, and Kevin Pohlman, most recently President of Patterson Animal Health, has been named Chief Operating Officer.

News for Patterson Companies Stock (PDCO)